Revium Rx. (RVRC)
OTCMKTS · Delayed Price · Currency is USD
1.670
0.00 (0.00%)
Apr 20, 2026, 4:00 PM EST

Revium Rx. Ratios and Metrics

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2009
Period Ending
Apr '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '09
101322352431
Market Cap Growth
276054.11%35.91%-55.43%20.71%5974.83%-
Enterprise Value
98272452441
Last Close Price
1.670.520.401.501.4915.00
PS Ratio
-----1.08
PB Ratio
14.744.591.1837.45110.750.82
P/TBV Ratio
56.0617.465.5637.45110.75-
P/FCF Ratio
-----0.22
P/OCF Ratio
-----0.22
EV/Sales Ratio
-----1.37
EV/FCF Ratio
-38.56----0.28
Debt / Equity Ratio
0.020.020-0.000.23
Debt / FCF Ratio
-----0.06
Net Debt / Equity Ratio
-0.38-0.38-0.27-0.86-1.090.23
Net Debt / EBITDA Ratio
0.750.751.481.190.36-
Net Debt / FCF Ratio
1.031.034.351.170.520.06
Asset Turnover
-----0.16
Quick Ratio
2.032.039.248.066.240.07
Current Ratio
2.262.269.589.326.530.41
Return on Equity (ROE)
-101.17%-101.17%-33.23%-110.77%--2.97%
Return on Assets (ROA)
-15.15%-15.15%-20.42%-62.04%--1.61%
Return on Capital Employed (ROCE)
-50.00%-50.00%-18.10%-72.00%-305.40%-9.70%
Earnings Yield
-13.26%-42.59%-15.09%-1.89%-2.81%-14.59%
FCF Yield
-2.50%-8.04%-5.22%-1.95%-1.91%454.66%
Buyback Yield / Dilution
-136.92%-136.92%12.69%-4.44%-48170.60%15.69%
Source: S&P Global Market Intelligence. Standard template. Financial Sources.